Dermata Expands Patent Portfolio with Issuance of New US Patent for Next-Generation Acne Treatment

Dermata Therapeutics, Inc. announced issuance by the US Patent and Trademark Office of a new patent for its XYNGARI™ product candidate for the treatment of acne.